SCHEMBL18329056

CC(=O)NC1C(O)[C@H](O[C@@H]2OC(CO[C@]3(OC=O)C[C@@H](O)[C@@H](C)C([C@H](O)[C@H](O)CO)O3)[C@H](O)CC2O)[C@H](CO)O[C@H]1OC1[C@@H](OCC2O[C@@H](O[C@@H]3C(CO)O[C@@H](O[C@@H]4C(CO)O[C@@H](C)C(NC(C)=O)[C@H]4O)C(NC(C)=O)[C@H]3O)C(O)[C@@H](O[C@H]3OC(CO)[C@@H](O)C(O)C3O[C@@H]3OC(CO)[C@@H](O[C@@H]4OC(CO)[C@H](O)[C@H](O[C@]5(OC=O)C[C@@H](O)[C@@H](C)C([C@H](O)[C@H](O)CO)O5)C4O)[C@H](O)C3NC(C)=O)[C@@H]2O)OC(CO)[C@@H](O)[C@@H]1O

nearest known ligand 0.47

Predicted protein targets (top 3)

	gene	UniProt	supporting neighbours	confidence
▸	MAG	P20916	9/20	0.47

▸	SIGLEC7	Q9Y286	6/20	0.46

▸	SELE	P16581	4/20	0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL17211088	1.00	MAG (0.47)	MAGSIGLEC7SELE
SCHEMBL12036212	1.00	MAG (0.47)	MAGSIGLEC7SELE
SCHEMBL17195867	0.96	SELE (0.47)	MAGSIGLEC7SELE
SCHEMBL4118092	0.96	SELE (0.47)	MAGSIGLEC7SELE
SCHEMBL16312021	0.96	SELE (0.47)	MAGSIGLEC7SELE
SCHEMBL17195870	0.96	SELE (0.47)	MAGSIGLEC7SELE
SCHEMBL16232781	0.96	SELE (0.47)	MAGSIGLEC7SELE
SCHEMBL16232771	0.96	SELE (0.47)	MAGSIGLEC7SELE
SCHEMBL12197080	0.96	SELE (0.47)	MAGSIGLEC7SELE
SCHEMBL4125539	0.96	SELE (0.47)	MAGSIGLEC7SELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-9802996-B2	Glycosylated polypeptide and drug composition containing said polypeptide	GLYTECH, INC. (JP)	2017-10-31	—	—	US	disclosed
US-20160368961-A1	Glycosylated Polypeptide and Drug Composition Containing said Polypeptide	GLYTECH, INC. (JP)	2016-12-22	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20160368961-A1	Glycosylated Polypeptide and Drug Composition Containing said Polypeptide	GIPR, SSTR3, SSTR4	MAG 766/4885SIGLEC7 92/4885SELE 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.